Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Opioid Conversion Guidelines

Patient Factors and Conversion Considerations

  • Individual patient factors such as prior opioid exposure, renal function, and concomitant medications can affect the appropriate conversion ratio, according to the National Comprehensive Cancer Network 1
  • Hydromorphone metabolites may accumulate in patients with renal insufficiency, potentially leading to increased adverse effects, as noted by the National Comprehensive Cancer Network 1

Conversion and Dosing

  • When converting from morphine to hydromorphone, start with the calculated equivalent dose and consider reducing by 25-30% to account for incomplete cross-tolerance, as recommended by the National Comprehensive Cancer Network 2
  • Monitor the patient closely after conversion for both efficacy and side effects, as advised by the National Comprehensive Cancer Network 1

Preferred Opioid Selection

  • Hydromorphone may be preferred in patients with morphine intolerance or those with renal insufficiency requiring lower doses of opioids, according to the National Comprehensive Cancer Network 1

REFERENCES

1

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

2

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010